Filing Details
- Accession Number:
- 0001209191-22-060596
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-12-09 19:59:46
- Reporting Period:
- 2022-11-21
- Accepted Time:
- 2022-12-09 19:59:46
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1858848 | Tenaya Therapeutics Inc. | TNYA | Biological Products, (No Disgnostic Substances) (2836) | 813789973 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1868501 | Deepak Srivastava | C/O Tenaya Therapeutics, Inc. 171 Oyster Point Blvd., 5Th Flr. South San Francisco CA 94080 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2022-11-21 | 230,769 | $2.60 | 372,435 | No | 4 | P | Indirect | See Footnote |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Indirect | See Footnote |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 191,666 | Direct |
Footnotes
- These shares are held directly by The J. David Gladstone Institutes for which the Reporting Person serves as President. The Reporting Person may be deemed to have voting and investment control over the shares. The Reporting Person disclaims beneficial ownership of these shares. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of any of the shares held by The J. David Gladstone Institutes for Section 16 or any other purpose.
Billionaire Hedge Funds
